Enquyst Technologies Inc.
Biomanufacturing platform for continuous production of high-purity biologics
- Sector
- Biotech
- Headquarters
- LOWELL, MA
- Latest Form D
- $6M, Jun 2025
- Total capital
- $6M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $6M
- 1 Form D · last Jun 2025
- 16 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 5 pending · first 2023
- Rank in peer group#59 of 342
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#59 · top 17%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Jason CriscioneResearcherExecutive Officer, Director, PromoterLinked by 2 patents
- James CaillouetteDirectorNamed in SEC Form D filings
- Vishal JainDirectorNamed in SEC Form D filings
- Youssef SebbanDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 7- PendingMultichannel Optical Switch For In-line Spectroscopic Compound AnalysisUSPTOApplication 19534282
- GrantedMultichannel Optical Switch For In-line Spectroscopic Compound AnalysisUSPTOUS 12,546,701
- GrantedProcess Technology For Biological Product Manufacturing And Downstream PurificationUSPTOUS 11,639,367
Show all 7 patent records
- Multichannel Optical Switch For In-line Spectroscopic Compound AnalysisJun 25, 2026 · Application 19534282Pending
- Multichannel Optical Switch For In-line Spectroscopic Compound AnalysisFeb 10, 2026 · US 12,546,701Granted
- Process Technology For Biological Product Manufacturing And Downstream PurificationMay 2, 2023 · US 11,639,367Granted
- Process Technology For Biological Product Manufacturing And Downstream PurificationSep 29, 2022 · Application 17840812Pending
- Multichannel Optical Switch For In-line Spectroscopic Compound AnalysisApplication 63611846Pending
- Multichannel Optical Switch For In-line Spectroscopic Compound AnalysisApplication PCTUS2024061200Pending
- Process Technology For Biological Product Manufacturing And Downstream PurificationApplication PCTUS2021050274Pending
Related companies, and why
- Latigo BiotherapeuticsSimilar federal contract value in Biotech · null in contracts
- Tamarind Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Animerra, Inc.Similar federal contract value in Biotech · null in contracts
- Quarry Thera, LLCSimilar federal contract value in Biotech · null in contracts
- Pheiron, Inc.Similar federal contract value in Biotech · null in contracts
- Aclipse Therapeutics LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .